It was also reported that upregulation of heparanase in myeloma and breast cancer cells is associated with increased release of Syndecan-1, Vascular Endothelial Growth Factor (VEGF), and Hepatocyte Growth Factor (HGF) in EVs, leading to increased endothelial invasion through the ECM [44]. The gene discussed is VEGFA; the disease is breast cancer.